Month: January 2018

Medical device manufacturer, Bedfont Scientific Ltd., received its ISO13485:2016 CMDCAS certificate

Established in 1976, Bedfont® Scientific Limited is a second generation family company that has specialised in the design and manufacture of exhaled breath and gas monitoring instruments for medical, scientific and industrial markets globally, for over 40 years. Bedfont is thrilled to announce that it has just received the ISO13485:2016 CMDCAS certificate which is a re-certificate on the new standard, 2016.

The multi export award winning British company is revered as a pioneer in the breath analysis market with their products now available in over 76 countries. Without the ISO13485 CMDCAS certificate, it is impossible to enter the Canadian market and so this recertification enables Bedfont to continue exporting to Canada, with hopes to grow sales in this area by over 20% in the next 5 years.

Louise Bateman, QA & RA manager, explains, “the ISO13485:2016 is the best internationally accepted accreditation to show compliance to regulators for the medical device industry. It is an extremely important recognition to our company’s commitment to produce the highest quality standard of medical device to sell to our customers.”

Jason Smith, Managing Director, adds, “For only a small company of 41 employees, to have exports account for roughly 80% of our annual turnover is a great achievement. We have a great RA team, led by Louise, who makes sure that, while we continue to innovate our products, they always remain at the highest standard for the medical device industry. Being such a niche manufacturer, and new MDDs, this no easy feat, but with dedication and support from all in the Bedfont family, I am proud that we have achieved the ISO13485:2016 CMDCAS certificate, making us eligible for the export awards we have won.”

Compiled by the European Business Awards, Bedfont Scientific Limited has been named as one of Europe’s best in the ‘Ones to Watch’ list.

The European Business Awards, sponsored by RSM, is a cross-industry and cross-border business competition. This year, the European Business Awards has compiled the ‘Ones to Watch’ list, to highlight companies who have shown exceptional achievement in one of the 12 categories but also reflect the programme’s core values of innovation, success and ethics. Bedfont, a second-generation family business that specialises in the design and manufacture of breath analysis medical devices, is proud to announce that it has been named on this list as one of Europe’s best.

First held in 2007, the European Business Awards aims to recognise and reward companies that help tackle the major issues faced by Europe and the world; unemployment, climate and environmental challenges, conflict and widespread poverty.

Jason Smith, Managing Director at Bedfont, says, “We are only a small company with such a niche concept as breath analysis, so we are humbled to have been including on the ‘Ones to Watch’ list. As a company, we endeavour to innovate and improve healthcare and are also determined to give back to the local community and are very conscious of our carbon footprint. This would not be possible without our employees, the Bedfont family. It is thanks to their hard work and dedication that we are eligible to be included on such a prestigious list.”

Adrian Tripp, CEO of the European Business Awards, commented “The talent, dedication and innovation at the heart of these companies jobs and opportunity, and is what drives their country’s prosperity. The ‘Ones to Watch’ lists will set a benchmark of success for the European business community.”

Jean Stephens, CEO of RSM, added, “To be listed as a ‘Ones to Watch’ is a real accolade. At RSM, we work with companies across Europe and beyond, advising them on all areas of their business and we are passionate about encouraging success and prosperity. We wish these dynamic companies every success in the future.”

Bedfont, who applied for the International Expansion award, will now have a chance to compete in the European Business Awards to become a National Winner in their country in May 2018.

Bedfont Scientific Ltd, based in Harrietsham, UK, returns to Arab Health 2018 to exhibit its wide range of breath analysis medical devices for medical applications

Established in 1976, Bedfont a second-generation family company that has specialised in the design and manufacture of exhaled breath and gas monitoring instruments for medical, scientific and industrial markets globally, for over 40 years. For the 8th year is a row, Bedfont returning to Arab Health, Dubai, to showcase their breath analysis medical devices, in their ambition to continue innovating and improving health worldwide.

Bedfont’s Medi-Gas Check range of medical pipeline testing equipment safeguards patients and staff against harmful gases. By testing the gas in the pipeline, its quantity and quality can be verified to ensure no harmful gas leaking, but also that the right gas is administered to patients. Their breath analysers include carbon monoxide (CO) monitors such as the Smokerlyzer®, used for smoking cessation, and the ToxCO®, used by emergency services to diagnose CO poisoning. The NObreath® FeNO monitor provides of airway inflammation for improving asthma management, and the Gastrolyzer® range aids in the detection of gastrointestinal disorders and food intolerances. Quick and non-invasive, breath analysis is the new blood test.

Andy Smith, Manager, says, “2018 marks the 8th year in a row that Bedfont® has attended the Arab Health exhibition and each year has been central to our growth in the Middle Eastern markets. One example would be our new Middle East Territory Manager, Ahmed . We met Ahmed at Arab Health and have worked alongside him as our distributor. The longevity of our relationship has been promising for our presence in the Middle East and so last year we employed Ahmed to help us grow further.”

To see Bedfont and their full range of products, please visit their stand H7E15.